Literature DB >> 15029248

A transcriptional network in polycystic kidney disease.

Lionel Gresh1, Evelyne Fischer, Andreas Reimann, Myriam Tanguy, Serge Garbay, Xinli Shao, Thomas Hiesberger, Laurence Fiette, Peter Igarashi, Moshe Yaniv, Marco Pontoglio.   

Abstract

Mutations in cystic kidney disease genes represent a major genetic cause of end-stage renal disease. However, the molecular cascades controlling the expression of these genes are still poorly understood. Hepatocyte Nuclear Factor 1beta (HNF1beta) is a homeoprotein predominantly expressed in renal, pancreatic and hepatic epithelia. We report here that mice with renal-specific inactivation of HNF1beta develop polycystic kidney disease. We show that renal cyst formation is accompanied by a drastic defect in the transcriptional activation of Umod, Pkhd1 and Pkd2 genes, whose mutations are responsible for distinct cystic kidney syndromes. In vivo chromatin immunoprecipitation experiments demonstrated that HNF1beta binds to several DNA elements in murine Umod, Pkhd1, Pkd2 and Tg737/Polaris genomic sequences. Our results uncover a direct transcriptional hierarchy between HNF1beta and cystic disease genes. Interestingly, most of the identified HNF1beta target gene products colocalize to the primary cilium, a crucial organelle that plays an important role in controlling the proliferation of tubular cells. This may explain the increased proliferation of cystic cells in MODY5 patients carrying autosomal dominant mutations in HNF1beta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029248      PMCID: PMC391068          DOI: 10.1038/sj.emboj.7600160

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  From cilia to cyst.

Authors:  Terry Watnick; Gregory Germino
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

2.  Factors involved in control of tissue-specific expression of albumin gene.

Authors:  S Cereghini; M Raymondjean; A G Carranca; P Herbomel; M Yaniv
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

Review 3.  Epithelial hyperplasia in human polycystic kidney diseases. Its role in pathogenesis and risk of neoplasia.

Authors:  J Bernstein; A P Evan; K D Gardner
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

4.  A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution.

Authors:  Edgar Otto; Julia Hoefele; Rainer Ruf; Adelheid M Mueller; Karl S Hiller; Matthias T F Wolf; Maria J Schuermann; Achim Becker; Ralf Birkenhäger; Ralf Sudbrak; Hans C Hennies; Peter Nürnberg; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2002-08-29       Impact factor: 11.025

5.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

Authors:  Vincent H Gattone; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

6.  Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis.

Authors:  Heike Olbrich; Manfred Fliegauf; Julia Hoefele; Andreas Kispert; Edgar Otto; Andreas Volz; Matthias T Wolf; Gürsel Sasmaz; Ute Trauer; Richard Reinhardt; Ralf Sudbrak; Corinne Antignac; Norbert Gretz; Gerd Walz; Bernhard Schermer; Thomas Benzing; Friedhelm Hildebrandt; Heymut Omran
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

7.  Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination.

Authors:  Edgar A Otto; Bernhard Schermer; Tomoko Obara; John F O'Toole; Karl S Hiller; Adelheid M Mueller; Rainer G Ruf; Julia Hoefele; Frank Beekmann; Daniel Landau; John W Foreman; Judith A Goodship; Tom Strachan; Andreas Kispert; Matthias T Wolf; Marie F Gagnadoux; Hubert Nivet; Corinne Antignac; Gerd Walz; Iain A Drummond; Thomas Benzing; Friedhelm Hildebrandt
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

8.  Distinct molecular and morphogenetic properties of mutations in the human HNF1beta gene that lead to defective kidney development.

Authors:  Silvia Bohn; Heike Thomas; Gülüzar Turan; Sian Ellard; Coralie Bingham; Andrew T Hattersley; Gerhart U Ryffel
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

9.  Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells.

Authors:  Surya M Nauli; Francis J Alenghat; Ying Luo; Eric Williams; Peter Vassilev; Xiaogang Li; Andrew E H Elia; Weining Lu; Edward M Brown; Stephen J Quinn; Donald E Ingber; Jing Zhou
Journal:  Nat Genet       Date:  2003-01-06       Impact factor: 38.330

10.  Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia.

Authors:  Christopher J Ward; David Yuan; Tatyana V Masyuk; Xiaofang Wang; Rachaneekorn Punyashthiti; Shelly Whelan; Robert Bacallao; Roser Torra; Nicholas F LaRusso; Vicente E Torres; Peter C Harris
Journal:  Hum Mol Genet       Date:  2003-08-12       Impact factor: 6.150

View more
  119 in total

1.  Functional specialization of sensory cilia by an RFX transcription factor isoform.

Authors:  Juan Wang; Hillel T Schwartz; Maureen M Barr
Journal:  Genetics       Date:  2010-10-05       Impact factor: 4.562

2.  A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation.

Authors:  Hung Ping Shih; Janel L Kopp; Manbir Sandhu; Claire L Dubois; Philip A Seymour; Anne Grapin-Botton; Maike Sander
Journal:  Development       Date:  2012-06-06       Impact factor: 6.868

Review 3.  Uromodulin in kidney injury: an instigator, bystander, or protector?

Authors:  Tarek M El-Achkar; Xue-Ru Wu
Journal:  Am J Kidney Dis       Date:  2012-01-23       Impact factor: 8.860

4.  Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression.

Authors:  Frank Zaucke; Joana M Boehnlein; Sarah Steffens; Roman S Polishchuk; Luca Rampoldi; Andreas Fischer; Andreas Pasch; Christoph W A Boehm; Anne Baasner; Massimo Attanasio; Bernd Hoppe; Helmut Hopfer; Bodo B Beck; John A Sayer; Friedhelm Hildebrandt; Matthias T F Wolf
Journal:  Hum Mol Genet       Date:  2010-02-18       Impact factor: 6.150

5.  Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.

Authors:  Zakir Hossain; Safiah Mohamed Ali; Hui Ling Ko; Jianliang Xu; Chee Peng Ng; Ke Guo; Zeng Qi; Sathivel Ponniah; Wanjin Hong; Walter Hunziker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

Review 6.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Genetic analyses reveal a requirement for Dicer1 in the mouse urogenital tract.

Authors:  Laura M Pastorelli; Sara Wells; Martin Fray; Adrian Smith; Tertius Hough; Brian D Harfe; Michael T McManus; Lee Smith; Adrian S Woolf; Michael Cheeseman; Andy Greenfield
Journal:  Mamm Genome       Date:  2009-01-24       Impact factor: 2.957

Review 8.  Uromodulin (Tamm-Horsfall protein): guardian of urinary and systemic homeostasis.

Authors:  Radmila Micanovic; Kaice LaFavers; Pranav S Garimella; Xue-Ru Wu; Tarek M El-Achkar
Journal:  Nephrol Dial Transplant       Date:  2020-01-01       Impact factor: 5.992

9.  Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway.

Authors:  Miguel A Garcia-Gonzalez; Luis F Menezes; Klaus B Piontek; Junya Kaimori; David L Huso; Terry Watnick; Luiz F Onuchic; Lisa M Guay-Woodford; Gregory G Germino
Journal:  Hum Mol Genet       Date:  2007-06-16       Impact factor: 6.150

10.  A mitotic transcriptional switch in polycystic kidney disease.

Authors:  Francisco Verdeguer; Stephanie Le Corre; Evelyne Fischer; Celine Callens; Serge Garbay; Antonia Doyen; Peter Igarashi; Fabiola Terzi; Marco Pontoglio
Journal:  Nat Med       Date:  2009-12-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.